Use discretion or consult a local health professional. Common symptoms of cold agglutinin disease include: Dizziness Fatigue Irritability Headaches Cold hands and feet which may be associated with ...

Discover how BioCryst Pharmaceuticals' patent for complement system inhibitors offers groundbreaking treatment options for various diseases.

Your Artstor image groups were copied to Workspace. The Artstor website will be retired on Aug 1st. The Journal of Infectious Diseases Vol. 41, No. 1, Jul., 1927 Precipitin, Lysin and Agglutinin Tests ...

which were partially offset by a $15.0 million one-time expense in the first quarter related to the discontinuation of systemic pegcetacoplan for cold agglutinin disease (CAD). Selling, General and ...

In a note to clients, the analysts at Mizuho cut the firm's price target for the stock to $52 from $60 per share, saying they have updated their model. APLS's stock is currently trading at $43.87, ...

Annexon (ANNX) is expected to provide updates from the phase III study evaluating its lead candidate, ANX005, for the treatment of GBS in the first-quarter earnings release.

In a note to clients, the analysts at Mizuho cut the firm's price target for the stock to $52 from $60 per share, saying they have updated their model. APLS's stock is currently trading at $43.87, ...

which were partially offset by a $15.0 million one-time expense in the first quarter related to the discontinuation of systemic pegcetacoplan for cold agglutinin disease (CAD). Selling, General and ...